Jeffrey Hessekiel - Nov 1, 2021 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
EVP and General Counsel
Signature
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Nov 1, 2021
Transactions value $
-$112,728
Form type
4
Date filed
11/3/2021, 08:12 PM
Previous filing
Oct 15, 2021
Next filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Sale -$113K -5.12K -0.8% $22.03 633K Nov 1, 2021 Direct F1, F2, F3
holding EXEL Common Stock 999 Nov 1, 2021 By 401(k) F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2020.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.06. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3 Includes 207,930 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F4 Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 1, 2021.